The FDA has launched a new pilot programme to be able to track-and-trace medicines by 2023 electronically and keep falsified drugs out of the US medical supply chain.The FDA have recruited Frank Yiannis, who had been at Walmart and helped them introduce blockchain to improve fruit and vegetable safety and Walmart’s ability to track and prove produce provenance.
The FDA said “For the drug track-and-trace system, our goals are to fully secure electronic product tracing, which provides a step-by-step account of where a drug product has been located and who has handled it. The aims are also to establish a more robust product verification to ensure that a drug product is legitimate and unaltered and to make sure that any party involved in handling drugs in the supply chain have the ability to spot and quarantine and investigate any suspect product”
